Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like 50+ Valeant Sales Reps May Have Jumped Ship to Synergy Pharma February 23, 2017 Biogen Shows Off More Positive Alzheimer???s Trial Data August 27, 2017 Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives October 12, 2017
